Learn More
Invitrogen™ CXCL9 Polyclonal Antibody
Goat Polyclonal Antibody
Marque: Invitrogen™ PA547020
Description
In sandwich ELISAs, less than 0.5% cross-reactivity with recombinant human (rh) CXCL9/MIG is observed and less than 0.005% cross-reactivity with recombinant mouse MIP-2, recombinant rat CINC-1, rhGRO alpha, rhGRO beta, and rhGRO gamma is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
MIG, also known as CXCL9, is a T-cell chemoattractant inducible by gamma interferon that is a member of the CXC chemokine family of cytokines.This gene is mapped to 4q21. It is noted that, although the best-described activities of the chemokines are as chemotactic factors, chemokines also have an effect on T-cell activation, angiogenesis, and HIV infection. While most CXC chemokines are chemotactic for neutrophils, MIG and INP10 are unusual and similar in being CXC chemokines that are chemotactic for lymphocytes and inactive in neutrophils.
Spécification
CXCL9 | |
Polyclonal | |
Unconjugated | |
CXCL9 | |
BB139920; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 9; CMK; crg-10; CXC; CXC motif chemokine; C-X-C motif chemokine 9; C-X-C motif chemokine ligand 9; CXCL; CXCL9; gamma interferon-induced monokine; gamma-interferon-induced monokine; HuMIG; M119; Mig; monokine induced by gamma interferon; monokine induced by interferon gamma; monokine induced by interferon-gamma; MuMIG; protein m119; SCYB9; small inducible cytokine B subfamily (Cys-X-Cys), member 9; small inducible cytokine B9; small-inducible cytokine B9 | |
Goat | |
Antigen affinity chromatography | |
RUO | |
17329 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
ELISA, Neutralization | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
P18340 | |
CXCL9 | |
E. coli-derived recombinant mouse CXCL9/MIG. | |
100 μg | |
Primary | |
Mouse | |
Antibody | |
IgG |
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.